Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Virulence|October 5, 2020
Exploring metal availability in the natural niche of Streptococcus pneumoniae to discover potential vaccine antigensLucille F van Beek, Kristin Surmann, H Bart van den Berg van Saparoea, et al.
Vaccine|February 1, 2026
Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studiesKaterina S Cheliotis, Patricia Gonzalez-Dias, Esther L German, et al.
Plos One|May 4, 2023
Comprehensive review of safety in Experimental Human Pneumococcal ChallengeRyan E Robinson, Christopher Myerscough, Nengjie He, et al.
Nature Immunology|October 31, 2018
Inflammation induced by influenza virus impairs human innate immune control of pneumococcusSimon P Jochems, Fernando Marcon, Beatriz F Carniel, et al.
Plos One|January 27, 2023
Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: An observational cohort studyNaomi F Walker, Rachel L Byrne, Ashleigh Howard, et al.
The Journal of Infection|December 15, 2021
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodiesSophie I Owen, Christopher T Williams, Gala Garrod, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2020
Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not ImmunogenicHugh Adler, Esther L German, Elena Mitsi, et al.
The Journal of Clinical Investigation|July 31, 2019
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Lancet. Microbe|February 16, 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trialKonstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated Streptococcus pneumoniae Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Pageof 5